EQL — EQL Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeSmall CapMomentum Trap

Annual balance sheet for EQL Pharma AB, fiscal year end - March 31st, SEK millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	PRESS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	21.7	10.3	26.6	41.2	44.4
Net Total Accounts Receivable
Net Total Receivables	11.9	18.4	25.6	37.6	51.7
Total Inventory
Prepaid Expenses
Total Current Assets	52.8	61.3	97.8	123	167
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.524	0.366	5.01	4.19	3.15
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	102	124	204	238	286
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.7	43.4	94.9	98.8	116
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	23.7	43.4	112	114	131
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	78.2	80.9	91.2	124	155
Total Liabilities & Shareholders' Equity	102	124	204	238	286
Total Common Shares Outstanding